TITLE

A 52-week prospective, cohort study of the effects of losartan with or without hydrochlorothiazide (HCTZ) in hypertensive patients with metabolic syndrome

AUTHOR(S)
Racine, N.; Hamet, P.; Sampalis, J. S.; Longo, N.; Bastien, N.
PUB. DATE
November 2010
SOURCE
Journal of Human Hypertension;Nov2010, Vol. 24 Issue 11, p739
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The impact of an ARB, with or without hydrochlorothiazide (HCTZ), on glycaemic factors and the risk for developing diabetes in hypertensive patients with the metabolic syndrome have not been fully assessed. This was a 52-week multicentre, prospective, phase-IV, open-label, cohort study of losartan or losartan/HCTZ in hypertensive patients with metabolic syndrome. All subjects were treated initially with losartan 50 mg day−1. Those not achieving target blood pressure (BP <140/90 mm Hg) were titrated sequentially to losartan 100 mg, losartan 100 mg/HCTZ 12.5 mg, losartan 100 mg/HCTZ 25 mg and finally to losartan 100 mg/HCTZ 25 mg and calcium-channel blocker (CCB), as required. The primary glycaemic outcome measure was change in fasting blood glucose (FBG) and glycosylated haemoglobin A1c (HbA1c) at 52 weeks of treatment. Among the 1897 potentially eligible patients enrolled in the study, 1714 fulfilled the screening criteria. During the 52-week treatment period of the study, FBG and HbA1c did not change significantly. Clinically important and statistically significant changes were observed for both the systolic (SBP) and diastolic BP (DBP) during the study treatment period, with an overall mean decrease of 16.95 mm Hg in SBP (P=0.001) and 9.84 mm Hg in DBP (P=0.001). The majority of the patients (77.3%) achieved a target BP of <140/90 mm Hg. In conclusion, losartan, either alone or in combination with HCTZ, is effective in managing hypertension without inducing any change in glycaemic parameters or increasing the risk for developing diabetes in hypertensive patients with the metabolic syndrome.
ACCESSION #
54401247

 

Related Articles

  • Better diabetes control needed among Haitian patients. Foster, Melissa // Endocrine Today;Jan2011, Vol. 9 Issue 1, p25 

    This article discusses a study on glycemic and blood pressure control among Haitians with diabetes.

  • Blood Pressure Drugs Stop Eye Disease from Progressing in People with Diabetes.  // Countdown;Fall 2009, Vol. 30 Issue 2, p10 

    The article reports on the study conducted in the U.S. which reveals that anti hypertensive agents may significantly prevent the progression of diabetic retinopathy, a common complication in type 1 diabetes. It states that the drugs losartan and enalapril act on the hormonal system controlled by...

  • New Insight into Improvement of Cardiovascular Outcomes with Intensive Glycemic Control in Patients with Metabolic Syndrome and Type 2 Diabetes Mellitus Included. Pei, Fei; Sun, Jian // Cell Biochemistry & Biophysics;Jan2015, Vol. 71 Issue 1, p9 

    The epidemiology of metabolic syndrome (MetS) is very concerning since this is a widespread chronic disease in adult and elderly population. Different epidemiological studies confirmed strong relationship between type 2 diabetes mellitus (DM2) inclusive MetS and the occurrence of microvascular...

  • Altered C-Fiber Function as an Indicator of Early Peripheral Neuropathy in Individuals With Impaired Glucose Tolerance. Green, Alistair Q.; Krishnan, Singhan; Finucane, Francis M.; Rayman, Gerry // Diabetes Care;Jan2010, Vol. 33 Issue 1, p174 

    OBJECTIVE -- This study explored the importance of glycemic burden compared with features of the metabolic syndrome in the pathogenesis of diabetic neuropathy by comparing C-fiber function in people with type 1 diabetes to that in people with impaired glucose tolerance (IGT). RESEARCH DESIGN AND...

  • Growing diabetes problem signals adherence challenges. BENDIX, JEFFREY // Medical Economics;6/10/2013, Vol. 90 Issue 11, p20 

    The article focuses on diabetes and its management. As stated in a report by the American Diabetes Association (ADA), the disease has an increase rate from 7-8 percent. Its management includes lifestyle changes along with drugs with three of its main symptoms being blood pressure, low-density...

  • Benefits of Tight Blood Pressure Control in Diabetic Patients With Hypertension. PARATI, GIANFRANCO; BILO, GRZEGORZ; OCHOA, JUAN E. // Diabetes Care;May2011 Supplement 2, Vol. 34, pS297 

    The article offers an interpretation of the UK Prospective Diabetes Study (UKPDS) which examined the sustained effects of improved glycemic control after years of extended follow-up in type 2 diabetic patients. The sustained effects, also known as legacy effect, aims to address the long-term...

  • Diabetes and GMS2: sensible and achievable targets? Hughes, Eugene; Barrett-Lee, P. // Update;5/6/2004, Vol. 68 Issue 8, p389 

    The targets for diabetes and the new GMS contract are deemed by some to be 'unrealistic' or 'unachievable.' There has been argument about the inclusion of some indicators and the exclusion of others. With regard to inclusion, the author says to the detractors that the new contract is an...

  • Weight Lost and Regained Still Helps in Diabetes.  // Clinician Reviews;Oct2008, Vol. 18 Issue 10, p16 

    The article discusses research being done on weight change and diabetes. It references a study by A. C. Feldstein et al, published in a 2008 issue of "Diabetes Care." Researchers revealed that weight loss has beneficial effects on glycemic and blood pressure control among diabetic persons. Data...

  • Adequacy of glycemic, lipid, and blood pressure management for patients with diabetes in a managed care setting. Beaton, Sarah J.; Nag, Soma S.; Gunter, Margaret J.; Gleeson, Jeremy M.; Sajjan, Shiva S.; Alexander, Charles M. // Diabetes Care;Mar2004, Vol. 27 Issue 3, p694 

    Objective: We conducted a retrospective study to evaluate the adequacy of glycemic, lipid, and blood pressure (BP) management for diabetic patients in a managed care organization (MCO).Research Design and Methods: Patients aged > or =18 years with diabetes (n=7,114)...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics